[Pharmacotherapy of states of deficient myocardial circulation. Pharmacologic aspects].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use*; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy*; D009206:Myocardium / Q000378:metabolism*; D010208:Papaverine / Q000627:therapeutic use*; D010634:Phenobarbital / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D014665:Vasodilator Agents; D004176:Dipyridamole; D010208:Papaverine; D010634:Phenobarbital
Die Pharmakotherapie der Mangeldurchblutungszustände des Myokards. Pharmakologische Aspekte.